BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N. The Bacterial Connection between the Oral Cavity and the Gut Diseases. J Dent Res 2020;99:1021-9. [PMID: 32464078 DOI: 10.1177/0022034520924633] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
2 Kumar S, Shukla R, Ranjan P, Kumar A. Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome. Clin Ther 2017;39:632-43. [PMID: 28237672 DOI: 10.1016/j.clinthera.2017.01.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
3 El-Salhy M, Hausken T, Hatlebakk JG. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients. 2019;11. [PMID: 31238507 DOI: 10.3390/nu11061415] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016;14:127-138. [PMID: 27175113 DOI: 10.5217/ir.2016.14.2.127] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
5 Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16:62. [PMID: 27296254 DOI: 10.1186/s12876-016-0470-z] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 14.5] [Reference Citation Analysis]
6 Webb DL. Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future. Best Pract Res Clin Gastroenterol 2019;40-41:101636. [PMID: 31594645 DOI: 10.1016/j.bpg.2019.101636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Liu H, Zeng X, Zhang G, Hou C, Li N, Yu H, Shang L, Zhang X, Trevisi P, Yang F, Liu Z, Qiao S. Maternal milk and fecal microbes guide the spatiotemporal development of mucosa-associated microbiota and barrier function in the porcine neonatal gut. BMC Biol 2019;17:106. [PMID: 31852478 DOI: 10.1186/s12915-019-0729-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
8 Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C, O'Donnell TA, Brierley SM, Ingraham HA, Julius D. Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways. Cell. 2017;170:185-198.e16. [PMID: 28648659 DOI: 10.1016/j.cell.2017.05.034] [Cited by in Crossref: 293] [Cited by in F6Publishing: 265] [Article Influence: 58.6] [Reference Citation Analysis]
9 Staudacher HM, Whelan K. The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66:1517-1527. [PMID: 28592442 DOI: 10.1136/gutjnl-2017-313750] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 26.8] [Reference Citation Analysis]
10 Chen T, Yin XL, Kang N, Wang XG, Li BS, Ji HJ, Zhang YQ, Bian LQ, Zhang BH, Wang FY, Tang XD. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats. Chin J Integr Med 2020;26:745-53. [PMID: 31768870 DOI: 10.1007/s11655-019-3034-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, Bharucha AE. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology. 2016;150:367-379.e1. [PMID: 26460205 DOI: 10.1053/j.gastro.2015.10.005] [Cited by in Crossref: 140] [Cited by in F6Publishing: 131] [Article Influence: 20.0] [Reference Citation Analysis]
12 Esquerre N, Basso L, Dubuquoy C, Djouina M, Chappard D, Blanpied C, Desreumaux P, Vergnolle N, Vignal C, Body-Malapel M. Aluminum Ingestion Promotes Colorectal Hypersensitivity in Rodents. Cell Mol Gastroenterol Hepatol 2019;7:185-96. [PMID: 30534582 DOI: 10.1016/j.jcmgh.2018.09.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
13 Wang Z, Xu CM, Liu YX, Wang XQ, Zhang L, Li M, Zhu SW, Xie ZJ, Wang PH, Duan LP, Zhu HQ. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome. Chin Med J (Engl). 2019;132:889-904. [PMID: 30958430 DOI: 10.1097/cm9.0000000000000192] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
14 Chen Q, Ren Y, Lu J, Bartlett M, Chen L, Zhang Y, Guo X, Liu C. A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response. Nutrients 2017;9:E1341. [PMID: 29232851 DOI: 10.3390/nu9121341] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
15 El-Salhy M, Hatlebakk JG. Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats. Mol Med Rep. 2016;14:4967-4974. [PMID: 27840918 DOI: 10.3892/mmr.2016.5902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ní Dhonnabháín R, Xiao Q, O'Malley D. Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids. Front Endocrinol (Lausanne) 2021;12:745190. [PMID: 34917022 DOI: 10.3389/fendo.2021.745190] [Reference Citation Analysis]
17 Sundin J, Stridsberg M, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects. Sci Rep 2018;8:16821. [PMID: 30429499 DOI: 10.1038/s41598-018-35241-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Aziz I, Törnblom H, Simrén M. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty? Current Opinion in Gastroenterology 2017;33:196-202. [DOI: 10.1097/mog.0000000000000348] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
19 Jia Y, Guo L, Yang S, Wu Q, Meng F. Effectiveness of probiotics in irritable bowel syndrome: methodological quality of meta-analyses and systematic reviews. Frontiers of Nursing 2019;6:115-21. [DOI: 10.2478/fon-2019-0018] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gazouli M, Wouters MM, Kapur-pojskić L, Bengtson M, Friedman E, Nikčević G, Demetriou CA, Mulak A, Santos J, Niesler B. Lessons learned — resolving the enigma of genetic factors in IBS. Nat Rev Gastroenterol Hepatol 2016;13:77-87. [DOI: 10.1038/nrgastro.2015.206] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
21 Wang X, Qi Q, Wang Y, Wu H, Jin X, Yao H, Jin D, Liu Y, Wang C. Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome. Chin Med. 2018;13:63. [PMID: 30574173 DOI: 10.1186/s13020-018-0220-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
22 Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
23 Shukla R, Ghoshal U, Ranjan P, Ghoshal UC. Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis. J Neurogastroenterol Motil 2018;24:628-42. [PMID: 30347939 DOI: 10.5056/jnm18130] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
24 Cui Y, Wang Q, Chang R, Zhou X, Xu C. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. J Agric Food Chem. 2019;67:2754-2762. [PMID: 30798598 DOI: 10.1021/acs.jafc.9b00080] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
25 Hayes CL, Dong J, Galipeau HJ, Jury J, McCarville J, Huang X, Wang XY, Naidoo A, Anbazhagan AN, Libertucci J, Sheridan C, Dudeja PK, Bowdish DME, Surette MG, Verdu EF. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci Rep 2018;8:14184. [PMID: 30242285 DOI: 10.1038/s41598-018-32366-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 12.3] [Reference Citation Analysis]
26 Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol. 2016;9:199-212. [PMID: 26929782 DOI: 10.1177/1756283x15621230] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
27 Aroniadis OC, Drossman DA, Simrén M. A Perspective on Brain–Gut Communication: The American Gastroenterology Association and American Psychosomatic Society Joint Symposium on Brain–Gut Interactions and the Intestinal Microenvironment. Psychosom Med 2017;79:847-56. [DOI: 10.1097/psy.0000000000000431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
28 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
29 Dlugosz A, Nowak P, D’Amato M, Mohammadian Kermani G, Nyström J, Abdurahman S, Lindberg G. Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2015;27:1747-1754. [PMID: 26387872 DOI: 10.1111/nmo.12670] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
30 Trzeciak P, Herbet M. Role of the Intestinal Microbiome, Intestinal Barrier and Psychobiotics in Depression. Nutrients 2021;13:927. [PMID: 33809367 DOI: 10.3390/nu13030927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Migacz-Gruszka K, Branicki W, Obtulowicz A, Pirowska M, Gruszka K, Wojas-Pelc A. What's New in the Pathophysiology of Alopecia Areata? The Possible Contribution of Skin and Gut Microbiome in the Pathogenesis of Alopecia - Big Opportunities, Big Challenges, and Novel Perspectives. Int J Trichology 2019;11:185-8. [PMID: 31728100 DOI: 10.4103/ijt.ijt_76_19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Lin X, Liu X, Xu J, Cheng KK, Cao J, Liu T, Liu Q, Zhong H, Shen G, Dong J, Chang X. Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome. Chin Med 2019;14:18. [PMID: 31080495 DOI: 10.1186/s13020-019-0240-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, Ross AB, Törnblom H, Simrén M, Öhman L. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells 2021;10:1459. [PMID: 34200772 DOI: 10.3390/cells10061459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Madisch A, Labenz C, Hollenz M, Gross M, Labenz J. [Therapeutic management of irritable bowel syndrome in the family doctor's practice - probiotics and phytotherapeutics are often used successfully]. MMW Fortschr Med 2020;162:7-13. [PMID: 32661893 DOI: 10.1007/s15006-020-0658-6] [Reference Citation Analysis]
35 Hynönen U, Zoetendal EG, Virtala AK, Shetty S, Hasan S, Jakava-Viljanen M, de Vos WM, Palva A. Molecular ecology of the yet uncultured bacterial Ct85-cluster in the mammalian gut. Anaerobe 2020;62:102104. [PMID: 31562947 DOI: 10.1016/j.anaerobe.2019.102104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Skogberg G, Jackson S, Åstrand A. Mechanisms of tolerance and potential therapeutic interventions in Alopecia Areata. Pharmacol Ther 2017;179:102-10. [PMID: 28546083 DOI: 10.1016/j.pharmthera.2017.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
37 Stengel A, Gourcerol G, Taché Y. Editorial: Neurogastroenterology - Focus on the Gut-Brain Axis. Front Psychiatry 2021;12:653910. [PMID: 33746807 DOI: 10.3389/fpsyt.2021.653910] [Reference Citation Analysis]
38 El-Salhy M. Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2015;9:1161-74. [PMID: 26162959 DOI: 10.1586/17474124.2015.1067138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
39 El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237 [PMID: 34025075 DOI: 10.3748/wjg.v27.i18.2219] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Reigstad CS, Linden DR, Szurszewski JH, Sonnenburg JL, Farrugia G, Kashyap PC. Correlated gene expression encoding serotonin (5-HT) receptor 4 and 5-HT transporter in proximal colonic segments of mice across different colonization states and sexes. Neurogastroenterol Motil 2016;28:1443-8. [PMID: 27072889 DOI: 10.1111/nmo.12840] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
41 Luo M, Zhuang X, Tian Z, Xiong L. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. BMC Gastroenterol 2021;21:14. [PMID: 33407171 DOI: 10.1186/s12876-020-01577-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Colomier E, Algera J, Melchior C. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front Pharmacol 2020;11:629026. [PMID: 33679391 DOI: 10.3389/fphar.2020.629026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Hattay P, Prusator DK, Tran L, Greenwood-van Meerveld B. Psychological stress-induced colonic barrier dysfunction: Role of immune-mediated mechanisms. Neurogastroenterol Motil 2017;29:e13043. [DOI: 10.1111/nmo.13043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
44 Dlugosz A, Winckler B, Lundin E, Zakikhany K, Sandström G, Ye W, Engstrand L, Lindberg G. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep. 2015;5:8508. [PMID: 25687743 DOI: 10.1038/srep08508] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
45 Boeckxstaens GE, Wouters MM. Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterol Motil. 2017;29. [PMID: 28027594 DOI: 10.1111/nmo.13007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
46 Midenfjord I, Borg A, Törnblom H, Simrén M. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:769-79. [DOI: 10.14309/ajg.0000000000001038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Zeevenhooven J, de Bruijn CMA, Vlieger A, Nieuwdorp M, Benninga MA. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial. BMJ Paediatr Open 2020;4:e000689. [PMID: 32864480 DOI: 10.1136/bmjpo-2020-000689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Camilleri M, Oduyebo I, Halawi H. Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol 2016;311:G777-84. [PMID: 27609770 DOI: 10.1152/ajpgi.00242.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
49 Zhao L, Ren P, Wang M, Wang J, He X, Gu J, Lu Y, Wu Y, Liu J, Wang L, Li H. Changes in intestinal barrier protein expression and intestinal flora in a rat model of visceral hypersensitivity. Neurogastroenterol Motil 2021;:e14299. [PMID: 34821442 DOI: 10.1111/nmo.14299] [Reference Citation Analysis]
50 Ratanasirintrawoot S, Israsena N. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016;22:367-382. [PMID: 27184041 DOI: 10.5056/jnm16023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
51 Jacenik D, Cygankiewicz AI, Fichna J, Mokrowiecka A, Małecka-panas E, Krajewska WM. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome. Molecular and Cellular Endocrinology 2018;471:89-96. [DOI: 10.1016/j.mce.2017.07.036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
52 De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M. Nutritional Keys for Intestinal Barrier Modulation. Front Immunol 2015;6:612. [PMID: 26697008 DOI: 10.3389/fimmu.2015.00612] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 13.6] [Reference Citation Analysis]
53 Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Cell Mol Gastroenterol Hepatol 2016;2:394-399.e2. [PMID: 28174725 DOI: 10.1016/j.jcmgh.2016.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Lu S, Zuo T, Zhang N, Shi H, Liu F, Wu J, Wang Y, Xue C, Tang Q. High throughput sequencing analysis reveals amelioration of intestinal dysbiosis by squid ink polysaccharide. Journal of Functional Foods 2016;20:506-15. [DOI: 10.1016/j.jff.2015.11.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
55 Liu G, Wang B, Huang Y, Li K, Ge W, Zhang M, Yue B, Kong M. The Growth Rate, Immune Status, Duodenal Development, and Cecal Microbial Diversity of 24-Day-Old Offspring of SD Rats Received Bacillus subtilis-Cu or CuSO4 During Pregnancy and Lactation Periods. Biol Trace Elem Res 2019;191:435-42. [PMID: 30788719 DOI: 10.1007/s12011-019-1638-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Gracie DJ, Ford AC. Symbiotics in irritable bowel syndrome – better than probiotics alone?: . Current Opinion in Clinical Nutrition and Metabolic Care 2015;18:485-9. [DOI: 10.1097/mco.0000000000000199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
57 Staudacher HM, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc. 2016;75:306-318. [PMID: 26908093 DOI: 10.1017/s0029665116000021] [Cited by in Crossref: 52] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
58 Bai T, Li Y, Xia J, Jiang Y, Zhang L, Wang H, Qian W, Song J, Hou X. Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome? J Neurogastroenterol Motil 2017;23:453-63. [PMID: 28044050 DOI: 10.5056/jnm16114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
59 Wen W, Zhang H, Shen J, Wei L, Shen S. Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol. Medicine (Baltimore). 2018;97:e12661. [PMID: 30290648 DOI: 10.1097/md.0000000000012661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
60 Padhy SK, Sahoo S, Mahajan S, Sinha SK. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract 2015;6:568-77. [PMID: 26752904 DOI: 10.4103/0976-3147.169802] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
61 Luo XC, Chen ZH, Xue JB, Zhao DX, Lu C, Li YH, Li SM, Du YW, Liu Q, Wang P, Liu M, Huang L. Infection by the parasitic helminth Trichinella spiralis activates a Tas2r-mediated signaling pathway in intestinal tuft cells. Proc Natl Acad Sci U S A 2019;116:5564-9. [PMID: 30819885 DOI: 10.1073/pnas.1812901116] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
62 McCullough R, McCullough J. Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop. Transl Gastroenterol Hepatol 2017;2:18. [PMID: 28447053 DOI: 10.21037/tgh.2017.03.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
63 Laterza L, Ianiro G, Scoleri I, Landi R, Bruno G, Scaldaferri F, Gaetani E, Campanale M, Gasbarrini A. Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2015;16:607-615. [PMID: 25641072 DOI: 10.1517/14656566.2015.1007951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
64 Xu WL, Lu G, Liang SJ, Wu XL, Pei LX, Geng H, Ning HX, Sun JH. Short chain fatty acids mediated flora-host interaction and irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(36): 5815-5822 [DOI: 10.11569/wcjd.v23.i36.5815] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Parthasarathy G, Chen J, Chia N, O'Connor HM, Gaskins HR, Bharucha AE. Reproducibility of assessing fecal microbiota in chronic constipation. Neurogastroenterol Motil 2017;29:1-10. [PMID: 28752633 DOI: 10.1111/nmo.13172] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
66 Biesiekierski JR, Jalanka J, Staudacher HM. Can Gut Microbiota Composition Predict Response to Dietary Treatments? Nutrients 2019;11:E1134. [PMID: 31121812 DOI: 10.3390/nu11051134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
67 Patterson KM, Vajdic TG, Martinez GJ, Feller AG, Reynolds JM. IL-17 and IL-17C Signaling Protects the Intestinal Epithelium against Diisopropyl Fluorophosphate Exposure in an Acute Model of Gulf War Veterans' Illnesses. Immune Netw 2021;21:e35. [PMID: 34796039 DOI: 10.4110/in.2021.21.e35] [Reference Citation Analysis]
68 Borde A, Åstrand A. Alopecia areata and the gut-the link opens up for novel therapeutic interventions. Expert Opin Ther Targets 2018;22:503-11. [PMID: 29808708 DOI: 10.1080/14728222.2018.1481504] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
69 El-Salhy M, Mazzawi T. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2018;12:439-445. [PMID: 29493330 DOI: 10.1080/17474124.2018.1447380] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
70 Stilling RM, Dinan TG, Cryan JF. The brain's Geppetto-microbes as puppeteers of neural function and behaviour? J Neurovirol 2016;22:14-21. [PMID: 26047662 DOI: 10.1007/s13365-015-0355-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
71 Cifarelli V, Ivanov S, Xie Y, Son NH, Saunders BT, Pietka TA, Shew TM, Yoshino J, Sundaresan S, Davidson NO, Goldberg IJ, Gelman AE, Zinselmeyer BH, Randolph GJ, Abumrad NA. CD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice. Cell Mol Gastroenterol Hepatol 2017;3:82-98. [PMID: 28066800 DOI: 10.1016/j.jcmgh.2016.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
72 Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Gastroenterology. 2016;151:e1-e8. [PMID: 27215658 DOI: 10.1053/j.gastro.2016.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
73 Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, Ro S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.J Neurogastroenterol Motil. 2021;27:19-34. [PMID: 33166939 DOI: 10.5056/jnm20149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
74 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21(25): 7621-7636 [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
75 Greenwood-Van Meerveld B, Johnson AC, Grundy D. Gastrointestinal Physiology and Function. Handb Exp Pharmacol. 2017;239:1-16. [PMID: 28176047 DOI: 10.1007/164_2016_118] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
76 Zhou Y, Qi X, Wen H, Zhang K, Zhang X, Li J, Li Y, Fan H. Identification, expression analysis, and functional characterization of motilin and its receptor in spotted sea bass (Lateolabrax maculatus). Gen Comp Endocrinol 2019;277:38-48. [PMID: 30771290 DOI: 10.1016/j.ygcen.2019.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Duboc H, Dior M, Coffin B. Le syndrome de l’intestin irritable : nouvelles pistes physiopathologiques et conséquences pratiques. La Revue de Médecine Interne 2016;37:536-43. [DOI: 10.1016/j.revmed.2015.12.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
78 Santilli AD, Dawson EM, Whitehead KJ, Whitehead DC. Nonmicrobicidal Small Molecule Inhibition of Polysaccharide Metabolism in Human Gut Microbes: A Potential Therapeutic Avenue. ACS Chem Biol 2018;13:1165-72. [DOI: 10.1021/acschembio.8b00309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
79 Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2015;42:3-11. [PMID: 25913530 DOI: 10.1111/apt.13227] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 14.1] [Reference Citation Analysis]
80 Nybacka S, Simrén M, Störsrud S, Törnblom H, Winkvist A, Lindqvist HM. Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome. PLoS One 2021;16:e0257331. [PMID: 34634050 DOI: 10.1371/journal.pone.0257331] [Reference Citation Analysis]
81 Ahluwalia B, Magnusson MK, Öhman L. Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Scand J Gastroenterol 2017;52:1185-93. [PMID: 28697651 DOI: 10.1080/00365521.2017.1349173] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
82 Quigley EM. Leaky gut – concept or clinical entity?: . Current Opinion in Gastroenterology 2016;32:74-9. [DOI: 10.1097/mog.0000000000000243] [Cited by in Crossref: 64] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
83 Polster A, Öhman L, Tap J, Derrien M, Le Nevé B, Sundin J, Törnblom H, Cvijovic M, Simrén M. A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome. Sci Rep 2021;11:5521. [PMID: 33750831 DOI: 10.1038/s41598-021-84686-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Inflamm Bowel Dis 2016;22:487-504. [PMID: 26588090 DOI: 10.1097/MIB.0000000000000602] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
85 Midenfjord I, Polster A, Sjövall H, Friberg P, Törnblom H, Simrén M. Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Sci Rep 2020;10:9794. [PMID: 32555219 DOI: 10.1038/s41598-020-66558-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
86 Gabrielli MG, Tomassoni D. Starch-enriched diet modulates the glucidic profile in the rat colonic mucosa. Eur J Nutr 2018;57:1109-21. [PMID: 28393287 DOI: 10.1007/s00394-017-1393-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
87 Ringel Y, Ringel-Kulka T. The Intestinal Microbiota and Irritable Bowel Syndrome. J Clin Gastroenterol. 2015;49 Suppl 1:S56-S59. [PMID: 26447966 DOI: 10.1097/mcg.0000000000000418] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
88 Tack J, Drossman DA. What's new in Rome IV? Neurogastroenterol Motil 2017;29. [PMID: 28303651 DOI: 10.1111/nmo.13053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
89 El-Salhy M, Hatlebakk JG, Gilja OH. Abnormalities in endocrine and immune cells are correlated in dextransulfatesodiuminduced colitis in rats. Mol Med Rep. 2017;15:12-20. [PMID: 27959399 DOI: 10.3892/mmr.2016.6023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
90 Müller B, Rasmusson AJ, Just D, Jayarathna S, Moazzami A, Novicic ZK, Cunningham JL. Fecal Short-Chain Fatty Acid Ratios as Related to Gastrointestinal and Depressive Symptoms in Young Adults. Psychosom Med 2021;83:693-9. [PMID: 34267089 DOI: 10.1097/PSY.0000000000000965] [Reference Citation Analysis]
91 Duan R, Zhu S, Wang B, Duan L. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review. Clin Transl Gastroenterol 2019;10:e00012. [PMID: 30829919 DOI: 10.14309/ctg.0000000000000012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
92 Peters SA, Edogawa S, Sundt WJ, Dyer RB, Dalenberg DA, Mazzone A, Singh RJ, Moses N, Smyrk TC, Weber C, Linden DR, MacNaughton WK, Turner JR, Camilleri M, Katzka DA, Farrugia G, Grover M. Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function. Am J Gastroenterol. 2017;112:913-923. [PMID: 28323272 DOI: 10.1038/ajg.2017.48] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
93 Buckley MM, O'Malley D. Development of an ex Vivo Method for Multi-unit Recording of Microbiota-Colonic-Neural Signaling in Real Time. Front Neurosci 2018;12:112. [PMID: 29535604 DOI: 10.3389/fnins.2018.00112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
94 Bennet SMP, Sundin J, Magnusson MK, Strid H, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation. Neurogastroenterol Motil 2018;30:e13468. [PMID: 30230134 DOI: 10.1111/nmo.13468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
95 Talley NJ, Holtmann G, Walker MM. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol. 2015;50:601-613. [PMID: 25917563 DOI: 10.1007/s00535-015-1076-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
96 De Simone V, van Baarle L, Matteoli G. Neurite outgrowth in symptomatic uncomplicated diverticular disease. Neurogastroenterol Motil 2019;31:e13680. [PMID: 31411366 DOI: 10.1111/nmo.13680] [Reference Citation Analysis]
97 Song YF, Pei LX, Chen L, Geng H, Yuan MQ, Xu WL, Wu J, Zhou JY, Sun JH. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model. Am J Chin Med 2020;48:77-90. [PMID: 31918565 DOI: 10.1142/S0192415X20500044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
98 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]
99 Sundin J, Öhman L, Simrén M. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosom Med 2017;79:857-67. [PMID: 28422780 DOI: 10.1097/PSY.0000000000000470] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
100 Bruzzese E, Pesce M, Sarnelli G, Guarino A. Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2018;14:753-60. [PMID: 29897844 DOI: 10.1080/17425255.2018.1488964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
101 Azpiroz F, Dubray C, Bernalier-donadille A, Cardot J, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study. Neurogastroenterol Motil 2017;29:e12911. [DOI: 10.1111/nmo.12911] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
102 Sundin J, Aziz I, Nordlander S, Polster A, Hu YOO, Hugerth LW, Pennhag AAL, Engstrand L, Törnblom H, Simrén M, Öhman L. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome. Sci Rep 2020;10:593. [PMID: 31953505 DOI: 10.1038/s41598-020-57468-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
103 Bednarska O, Walter SA, Casado-Bedmar M, Ström M, Salvo-Romero E, Vicario M, Mayer EA, Keita ÅV. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Gastroenterology 2017;153:948-960.e3. [PMID: 28711627 DOI: 10.1053/j.gastro.2017.06.051] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
104 Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2016; May 27. [Epub ahead of print]. [PMID: 27237431 DOI: 10.1016/j.cgh.2016.05.027] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
105 Ogilvie LA, Jones BV. The human gut virome: a multifaceted majority. Front Microbiol 2015;6:918. [PMID: 26441861 DOI: 10.3389/fmicb.2015.00918] [Cited by in Crossref: 123] [Cited by in F6Publishing: 104] [Article Influence: 17.6] [Reference Citation Analysis]
106 Wolf PG, Parthasarathy G, Chen J, O'Connor HM, Chia N, Bharucha AE, Gaskins HR. Assessing the colonic microbiome, hydrogenogenic and hydrogenotrophic genes, transit and breath methane in constipation. Neurogastroenterol Motil 2017;29:1-9. [PMID: 28295896 DOI: 10.1111/nmo.13056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
107 Low EXS, Mandhari MNKA, Herndon CC, Loo EXL, Tham EH, Siah KTH. Parental, Perinatal, and Childhood Risk Factors for Development of Irritable Bowel Syndrome: A Systematic Review. J Neurogastroenterol Motil 2020;26:437-46. [PMID: 32989183 DOI: 10.5056/jnm20109] [Reference Citation Analysis]
108 Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, Mendoza-Vargas A, Granados-Portillo O, Meraz-Cruz N, Palacios-González B. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct 2021;12:3206-18. [PMID: 33877245 DOI: 10.1039/d0fo03162c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]